203 related articles for article (PubMed ID: 35053185)
1. Smell Detection Agent Optimisation Framework and Systems Biology Approach to Detect Dys-Regulated Subnetwork in Cancer Data.
Sivan SL; Sukumara Pillai VCS
Biomolecules; 2021 Dec; 12(1):. PubMed ID: 35053185
[TBL] [Abstract][Full Text] [Related]
2. Incorporating topological information for predicting robust cancer subnetwork markers in human protein-protein interaction network.
Khunlertgit N; Yoon BJ
BMC Bioinformatics; 2016 Oct; 17(Suppl 13):351. PubMed ID: 27766944
[TBL] [Abstract][Full Text] [Related]
3. Hsa-mir-3163 and CCNB1 may be potential biomarkers and therapeutic targets for androgen receptor positive triple-negative breast cancer.
Qiu P; Guo Q; Yao Q; Chen J; Lin J
PLoS One; 2021; 16(11):e0254283. PubMed ID: 34797837
[TBL] [Abstract][Full Text] [Related]
4. Integrated network analysis and machine learning approach for the identification of key genes of triple-negative breast cancer.
Naorem LD; Muthaiyan M; Venkatesan A
J Cell Biochem; 2019 Apr; 120(4):6154-6167. PubMed ID: 30302816
[TBL] [Abstract][Full Text] [Related]
5. Identification of hub subnetwork based on topological features of genes in breast cancer.
Zhuang DY; Jiang L; He QQ; Zhou P; Yue T
Int J Mol Med; 2015 Mar; 35(3):664-74. PubMed ID: 25573623
[TBL] [Abstract][Full Text] [Related]
6. An integrative analysis of gene expression and molecular interaction data to identify dys-regulated sub-networks in inflammatory bowel disease.
Muraro D; Simmons A
BMC Bioinformatics; 2016 Jan; 17():42. PubMed ID: 26787018
[TBL] [Abstract][Full Text] [Related]
7. GSNFS: Gene subnetwork biomarker identification of lung cancer expression data.
Doungpan N; Engchuan W; Chan JH; Meechai A
BMC Med Genomics; 2016 Dec; 9(Suppl 3):70. PubMed ID: 28117655
[TBL] [Abstract][Full Text] [Related]
8. BMRF-MI: integrative identification of protein interaction network by modeling the gene dependency.
Shi X; Wang X; Shajahan A; Hilakivi-Clarke L; Clarke R; Xuan J
BMC Genomics; 2015; 16 Suppl 7(Suppl 7):S10. PubMed ID: 26099273
[TBL] [Abstract][Full Text] [Related]
9. Screening and Identification of Key Biomarkers in Inflammatory Breast Cancer Through Integrated Bioinformatic Analyses.
Wu J; Lv Q; Huang H; Zhu M; Meng D
Genet Test Mol Biomarkers; 2020 Aug; 24(8):484-491. PubMed ID: 32598242
[No Abstract] [Full Text] [Related]
10. Integrated analysis of differentially expressed genes and pathways in triple‑negative breast cancer.
Peng C; Ma W; Xia W; Zheng W
Mol Med Rep; 2017 Mar; 15(3):1087-1094. PubMed ID: 28075450
[TBL] [Abstract][Full Text] [Related]
11. A random forest classifier predicts recurrence risk in patients with ovarian cancer.
Cheng L; Li L; Wang L; Li X; Xing H; Zhou J
Mol Med Rep; 2018 Sep; 18(3):3289-3297. PubMed ID: 30066910
[TBL] [Abstract][Full Text] [Related]
12. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
[TBL] [Abstract][Full Text] [Related]
13. Identification of differentially expressed genes between triple and non-triple-negative breast cancer using bioinformatics analysis.
Zhai Q; Li H; Sun L; Yuan Y; Wang X
Breast Cancer; 2019 Nov; 26(6):784-791. PubMed ID: 31197620
[TBL] [Abstract][Full Text] [Related]
14. Identification of core genes and potential molecular mechanisms in breast cancer using bioinformatics analysis.
Liu F; Wu Y; Mi Y; Gu L; Sang M; Geng C
Pathol Res Pract; 2019 Jul; 215(7):152436. PubMed ID: 31076281
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms associated with breast cancer based on integrated gene expression profiling by bioinformatics analysis.
Wu D; Han B; Guo L; Fan Z
J Obstet Gynaecol; 2016 Jul; 36(5):615-21. PubMed ID: 26804550
[TBL] [Abstract][Full Text] [Related]
16. Integrated systems approach identifies risk regulatory pathways and key regulators in coronary artery disease.
Zhang Y; Liu D; Wang L; Wang S; Yu X; Dai E; Liu X; Luo S; Jiang W
J Mol Med (Berl); 2015 Dec; 93(12):1381-90. PubMed ID: 26208504
[TBL] [Abstract][Full Text] [Related]
17. A Network-Based Methodology to Identify Subnetwork Markers for Diagnosis and Prognosis of Colorectal Cancer.
Al-Harazi O; Kaya IH; El Allali A; Colak D
Front Genet; 2021; 12():721949. PubMed ID: 34790220
[TBL] [Abstract][Full Text] [Related]
18. Key signaling pathways, genes and transcription factors associated with hepatocellular carcinoma.
Wang J; Tian Y; Chen H; Li H; Zheng S
Mol Med Rep; 2018 Jun; 17(6):8153-8160. PubMed ID: 29658607
[TBL] [Abstract][Full Text] [Related]
19. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases.
Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P
Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537
[No Abstract] [Full Text] [Related]
20. Discovery of the Anti-Tumor Mechanism of Calycosin Against Colorectal Cancer by Using System Pharmacology Approach.
Huang C; Li R; Shi W; Huang Z
Med Sci Monit; 2019 Jul; 25():5589-5593. PubMed ID: 31352466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
